These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 11728950

  • 1. Steroid therapy and urinary transforming growth factor-beta1 in IgA nephropathy.
    Haramaki R, Tamaki K, Fujisawa M, Ikedo H, Haramaki N, Okuda S.
    Am J Kidney Dis; 2001 Dec; 38(6):1191-8. PubMed ID: 11728950
    [Abstract] [Full Text] [Related]

  • 2. The effects of dual blockade of the renin-angiotensin system on urinary protein and transforming growth factor-beta excretion in 2 groups of patients with IgA and diabetic nephropathy.
    Song JH, Lee SW, Suh JH, Kim ES, Hong SB, Kim KA, Kim MJ.
    Clin Nephrol; 2003 Nov; 60(5):318-26. PubMed ID: 14640237
    [Abstract] [Full Text] [Related]

  • 3. Effect of losartan and amlodipine on proteinuria and transforming growth factor-beta1 in patients with IgA nephropathy.
    Park HC, Xu ZG, Choi S, Goo YS, Kang SW, Choi KH, Ha SK, Lee HY, Han DS.
    Nephrol Dial Transplant; 2003 Jun; 18(6):1115-21. PubMed ID: 12748343
    [Abstract] [Full Text] [Related]

  • 4. Urinary transforming growth factor-beta 1 in various types of nephropathy.
    De Muro P, Faedda R, Fresu P, Masala A, Cigni A, Concas G, Mela MG, Satta A, Carcassi A, Sanna GM, Cherchi GM.
    Pharmacol Res; 2004 Mar; 49(3):293-8. PubMed ID: 14726227
    [Abstract] [Full Text] [Related]

  • 5. Value of urinary levels of interleukin-6, epidermal growth factor, monocyte chemoattractant protein type1 and transforming growth factor β1 in predicting the extent of fibrosis lesions in kidney biopsies of patients with IgA nephropathy.
    Segarra-Medrano A, Carnicer-Caceres C, Valtierra-Carmeno N, Agraz-Pamplona I, Ramos-Terrades N, Jatem Escalante E, Ostos-Roldan E.
    Nefrologia; 2017 Mar; 37(5):531-538. PubMed ID: 28946966
    [Abstract] [Full Text] [Related]

  • 6. ACE inhibitors attenuate expression of renal transforming growth factor-beta1 in humans.
    Shin GT, Kim SJ, Ma KA, Kim HS, Kim D.
    Am J Kidney Dis; 2000 Nov; 36(5):894-902. PubMed ID: 11054345
    [Abstract] [Full Text] [Related]

  • 7. Transforming growth factor-beta(1) in the kidney and urine of patients with glomerular disease and proteinuria.
    Goumenos DS, Tsakas S, El Nahas AM, Alexandri S, Oldroyd S, Kalliakmani P, Vlachojannis JG.
    Nephrol Dial Transplant; 2002 Dec; 17(12):2145-52. PubMed ID: 12454225
    [Abstract] [Full Text] [Related]

  • 8. Urinary Transforming Growth Factor-beta 1 as a marker of response to immunosuppressive treatment, in patients with crescentic nephritis.
    Goumenos DS, Kalliakmani P, Tsakas S, Sotsiou F, Vlachojannis JG.
    BMC Nephrol; 2005 Dec 20; 6():16. PubMed ID: 16367998
    [Abstract] [Full Text] [Related]

  • 9. Urinary interleukin-6 (IL-6) and transforming growth factor (TGF-β) levels in corticosteroidtreated patients with IgA nephropathy.
    Kalliakmani P, Nakopoulou L, Tsakas S, Gerolymos M, Papasotiriou M, Goumenos DS.
    Clin Nephrol; 2011 Aug 20; 76(2):144-50. PubMed ID: 21762647
    [Abstract] [Full Text] [Related]

  • 10. Roles of TGF-beta1 and apoptosis in the progression of glomerulosclerosis in human IgA nephropathy.
    Chihara Y, Ono H, Ishimitsu T, Ono Y, Ishikawa K, Rakugi H, Ogihara T, Matsuoka H.
    Clin Nephrol; 2006 Jun 20; 65(6):385-92. PubMed ID: 16792132
    [Abstract] [Full Text] [Related]

  • 11. Effect of IgA aggregates on transforming growth factor-beta1 production in human mesangial cells and the intraglomerular expression of transforming growth factor-beta1 in patients with IgA nephropathy.
    Han SY, Ihm CG, Cha DR, Kang YS, Han KH, Kim HK, Han JY.
    Korean J Intern Med; 2005 Mar 20; 20(1):40-7. PubMed ID: 15906952
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of Modified Huangqi Chifeng decoction in alleviating renal fibrosis in rats with IgA nephropathy by inhibiting the TGF-β1/Smad3 signaling pathway through exosome regulation.
    Zhao M, Yang B, Li L, Si Y, Chang M, Ma S, Li R, Wang Y, Zhang Y.
    J Ethnopharmacol; 2022 Mar 01; 285():114795. PubMed ID: 34737009
    [Abstract] [Full Text] [Related]

  • 13. Localization of transforming growth factors beta1 and beta2 and epidermal growth factor in IgA nephropathy.
    Taniguchi Y, Yorioka N, Masaki T, Asakimori Y, Yamashita K, Yamakido M.
    Scand J Urol Nephrol; 1999 Aug 01; 33(4):243-7. PubMed ID: 10515087
    [Abstract] [Full Text] [Related]

  • 14. Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis.
    Del Prete D, Gambaro G, Lupo A, Anglani F, Brezzi B, Magistroni R, Graziotto R, Furci L, Modena F, Bernich P, Albertazzi A, D'Angelo A, Maschio G.
    Kidney Int; 2003 Jul 01; 64(1):149-59. PubMed ID: 12787405
    [Abstract] [Full Text] [Related]

  • 15. [Urine excretion of a monocytic chemotaxic protein-1 and a transforming growth factor beta1 as an indicator of chronic glomerulonephritis progression].
    Bobkova IN, Chebotareva NV, Kozlovskaia LV, Varshavskiĭ VA, Golitsyna EP.
    Ter Arkh; 2006 Jul 01; 78(5):9-14. PubMed ID: 16889042
    [Abstract] [Full Text] [Related]

  • 16. Urinary transforming growth factor-beta 1 in membranous glomerulonephritis.
    Honkanen E, Teppo AM, Törnroth T, Groop PH, Grönhagen-Riska C.
    Nephrol Dial Transplant; 1997 Dec 01; 12(12):2562-8. PubMed ID: 9430852
    [Abstract] [Full Text] [Related]

  • 17. Glomerular transforming growth factor-beta1 mRNA as a marker of glomerulosclerosis-application in renal biopsies.
    Yang CW, Hsueh S, Wu MS, Lai PC, Huang JY, Wu CH, Hu SA, Chen JF, Huang CC.
    Nephron; 1997 Dec 01; 77(3):290-7. PubMed ID: 9375822
    [Abstract] [Full Text] [Related]

  • 18. Urinary transforming growth factor-beta1 excretion in renal allograft recipients during the early post-transplantation period.
    Goumenos DS, Tsakas S, Karavias D, Savidaki I, Karatzas T, Vlachojannis JG.
    Ren Fail; 2003 Jul 01; 25(4):561-8. PubMed ID: 12911160
    [Abstract] [Full Text] [Related]

  • 19. Serum miR-192 Is Related to Tubulointerstitial Lesion and Short-Term Disease Progression in IgA Nephropathy.
    Fan Q, Lu R, Zhu M, Yan Y, Guo X, Qian Y, Zhang L, Dai H, Ni Z, Gu L.
    Nephron; 2019 Jul 01; 142(3):195-207. PubMed ID: 30808829
    [Abstract] [Full Text] [Related]

  • 20. Urinary transforming growth factor-beta in patients with glomerular diseases.
    Murakami K, Takemura T, Hino S, Yoshioka K.
    Pediatr Nephrol; 1997 Jun 01; 11(3):334-6. PubMed ID: 9203185
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.